Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20833310 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A3SLC6A4KMT2ATSHR | |
| SCHEMBL28765067 | 0.77 | SLC6A3 (0.49) | SLC6A2SLC6A3SLC6A4TSHR | |
| SCHEMBL27682288 | 0.77 | SLC6A3 (0.49) | SLC6A2SLC6A3SLC6A4TSHR | |
| SCHEMBL22461794 | 0.77 | SLC6A3 (0.48) | SLC6A2SLC6A3SLC6A4TSHR | |
| SCHEMBL25339415 | 0.75 | SLC6A2 (0.52) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL22461896 | 0.75 | SLC6A2 (0.52) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL22260324 | 0.75 | SLC6A2 (0.52) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL6889303 | 0.75 | SLC6A2 (0.52) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL5195661 | 0.75 | TSHR (0.49) | KMT2ATSHR | |
| SCHEMBL20833040 | 0.75 | SLC6A2 (0.52) | SLC6A2SLC6A3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718638-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | SLC6A2 2493/4885SLC6A3 3086/4885SLC6A4 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.